SCHEMBL21929470

SCHEMBL21929470

Cc1c(CN2CCN([S+](C)[O-])CC2)cc2c(N3CCOCC3)nc(-c3cnc(NC(=O)NC(C)C)cc3C(F)(F)F)nn12

nearest known ligand 0.52

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 13/20 0.52
PIK3R1 P27986 11/20 0.51
PIK3CD O00329 3/20 0.48
PIK3CB P42338 3/20 0.48
RAF1 P04049 1/20 0.48
MTOR P42345 2/20 0.43
PIK3CG P48736 2/20 0.41
MAPK1 P28482 3/20 0.35
PARP1 P09874 2/20 0.35
KCNH2 Q12809 1/20 0.34
PARP2 Q9UGN5 1/20 0.34
CNR2 P34972 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23434547 0.92 PIK3R1 (0.60) PIK3CAPIK3R1PIK3CDPIK3CBRAF1
SCHEMBL23434892 0.90 PIK3CA (0.60) PIK3CAPIK3R1PIK3CDPIK3CBRAF1
SCHEMBL21929467 0.89 PIK3CA (0.65) PIK3CAPIK3R1PIK3CDPIK3CBRAF1
SCHEMBL23434643 0.84 PIK3CA (0.55) PIK3CAPIK3R1PIK3CDPIK3CBMTOR
SCHEMBL21929464 0.82 PIK3CA (0.75) PIK3CAPIK3R1PIK3CDPIK3CBRAF1
SCHEMBL22006217 0.81 PIK3CA (0.76) PIK3CAPIK3R1PIK3CDPIK3CBRAF1
SCHEMBL21929465 0.80 PIK3CA (0.63) PIK3CAPIK3R1PIK3CDPIK3CBRAF1
SCHEMBL21929585 0.80 PIK3CA (0.65) PIK3CAPIK3R1PIK3CDPIK3CBRAF1
SCHEMBL21929463 0.79 PIK3CA (0.75) PIK3CAPIK3R1PIK3CDPIK3CBRAF1
SCHEMBL21929583 0.79 PIK3CA (0.77) PIK3CAPIK3R1PIK3CDPIK3CBRAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3643717-A1 7-SITE SUBSTITUTED PYRROLE TRIAZINE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, AND PREPARATION METHOD THEREFOR AND USES THEREOF Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2020-04-29 EP disclosed